Skip to main content
CFOO
OTC Life Sciences

China Foods Holdings Reports Revenue Collapse to $255 and Ineffective Disclosure Controls

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.664
Mkt Cap
$13.446M
52W Low
$0.05
52W High
$11
52W Position info
1228% above low
Off High info
94% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CFOO has more than doubled off its 52-week low of $0.05.

Summary

China Foods Holdings reported a near-total revenue collapse to $255 for H1 2026 and ineffective disclosure controls, while relying on controlling shareholder support to address going concern.


Key Events · Earnings and Guidance · CFOO

  • Revenue Collapse

    Revenue for the six months ended June 30, 2026 was $255, down from $142,255 in the prior-year period. Healthcare product sales fell to $77 from $142,171.

  • Ineffective Disclosure Controls

    Management concluded disclosure controls and procedures were not effective as of June 30, 2026, meaning information may not be recorded, processed, or reported accurately.

  • Going Concern Assessment

    Current liabilities exceeded current assets by $1,451,924 and accumulated deficit was $2,655,563. Management concluded no substantial doubt about going concern due to controlling shareholder support agreements.

  • Controlling Shareholder Support

    The controlling shareholder entered into legally binding, unconditional, and enforceable agreements to provide financial support for at least the next 12 months.


Analysis · CFOO · Life Sciences

Revenue fell to $255 for the first half of 2026 from $142,255 a year earlier, a near-total collapse in sales. Management also concluded disclosure controls and procedures were not effective as of June 30, 2026. The company has a working capital deficit of $1.45 million and an accumulated deficit of $2.66 million, but the controlling shareholder has provided legally binding financial support for at least 12 months, which management says removes substantial doubt about going concern.

At the time of this filing, CFOO was trading at $0.66 on OTC in the Life Sciences sector, with a market capitalization of approximately $13.4M. The 52-week trading range was $0.05 to $11.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CFOO - Latest Insights

CFOO
May 15, 2026, 3:45 PM EDT
Filing Type: 10-Q
Importance Score:
9
CFOO
Apr 15, 2026, 6:20 PM EDT
Filing Type: 10-K
Importance Score:
9